BioForce Nanosciences (BFNH) Stock Price, News & Analysis

Company Overview

BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www.bioforceeclipse.com, as well as through social media and telemarketing channels. BioForce Nanosciences Holdings, Inc. is based in Virginia Beach, Virginia.

Key Stats

• Today's Range: $0.45 to $0.45
• 50-Day Range: $0.45 to $0.58
• 52-Week Range: $0.16 to $2.07
• Volume: 400 shs
• Average Volume: 1,134 shs
• Market Capitalization: $15.08 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BFNH Stock Analysis - Frequently Asked Questions

How have BFNH shares performed this year?

BioForce Nanosciences' stock was trading at $0.3415 on January 1st, 2025. Since then, BFNH shares have increased by 31.8% and is now trading at $0.45.
View the best growth stocks for 2025 here.

How were BioForce Nanosciences' earnings last quarter?

BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) released its quarterly earnings results on Tuesday, May, 13th. The company reported ($0.03) earnings per share for the quarter.

How do I buy shares of BioForce Nanosciences?

Shares of BFNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of BioForce Nanosciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BioForce Nanosciences investors own include Nano One Materials (NANO) and Charlotte's Web (CWBHF).

Company Calendar

• Last Earnings: 5/13/2025
• Today: 6/19/2025
• Next Earnings (Estimated): 8/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: OTCMKTS:BFNH
• CIK: 1310488
• Web: www.bioforceeclipse.com
• Phone: (757) 306-6090
• Fax: 757-306-6092
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$490 thousand
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -30,513.47%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.05
• Quick Ratio: 0.05

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.07) per share
• Price / Book: -6.43

Miscellaneous

• Outstanding Shares: 33,520,000
• Free Float: 20,267,000
• Market Cap: $15.08 million
• Optionable: Not Optionable
• Beta: -1.22